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Abstract:  
 
Background: Tuberculosis (TB) remains one of the leading public health challenges in Nigeria and the burden is still high. 
There is hence a need for continuous characterization of mycobacteria to obtain current data that will aid the ongoing TB 
prevention and control programme. The aim of this study was to phenotypically characterize mycobacteria isolates 
recovered from clinical specimens of patients with tuberculosis in Kaduna State, Nigeria.  
Methods: Two thousand, two hundred and twelve (2212) sputum samples were collected from patients clinically 
suspected to have TB in three different zones of Kaduna State, Nigeria, between May 2017 and October, 2018. Samples 
were processed by decontaminating with NaOH-Citrate N-acetyl-L-Cystein method for Ziehl Neelsen (ZN) AFB microscopy 
and culture on Lowenstein Jensen (LJ) slants which were incubated at 37ᵒC for 8 weeks. Positive LJ cultures were further 
analyzed with a rapid TB antigen assay (SD-Bioline) to differentiate Mycobacterium tuberculosis complex (MTBC) from 
Non Tuberculous Mycobacteria (NTM). 
Results: Out of the 2212 patients with suspected TB, 300 (13.6%) were positive for AFB by microscopy with Zone A 
(Kaduna North) having the highest AFB positive cases of 169 (15.2%). Of the 300 AFB positive samples, 272 (91.0%) 
were culture positive on LJ medium, 18 (6.0%) were culture negative and 10 (3.0%) were culture contaminated. Result of 
the distribution of mycobacteria among infected patients within the study area revealed that 219 (80.5%) were infected 
with MTBC, 42 (15.4%) with NTM and 11 (4.0%) with both MTBC and NTM.  
Conclusion: A relatively high number of TB in the study area was caused by NTM. There is need for advanced diagnostic 
tools that can differentiate MTBC and NTM strains among TB patients in all TB Reference Laboratories in Nigeria.   
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Contexte: La tuberculose reste l’un des principaux problèmes de santé publique au Nigéria et le fardeau est encore lourd. 
Il est donc nécessaire de caractériser en permanence les mycobactéries pour obtenir les données actuelles qui aideront le 
programme de prévention et de contrôle de la tuberculose en cours. Le but de cette étude était de caractériser 
phénotypiquement les isolats de mycobactéries récupérés à partir d'échantillons cliniques de patients atteints de 
tuberculose dans l'État de Kaduna, au Nigéria.                           
Méthodes: Deux mille douze cent douze (2212) échantillons d'expectorations ont été prélevés chez des patients 
cliniquement suspects de tuberculose dans trois zones différentes de l'État de Kaduna, au Nigéria, entre mai 2017 et 
octobre 2018. Les échantillons ont été traités par décontamination au NaOH-citrate. Méthode N-acétyl-L-Cystéine pour la 
microscopie AFB de Ziehl Neelsen (ZN) et culture sur des pentes de Lowenstein Jensen (LJ) qui ont été incubées à 37 ° C 
pendant 8 semaines. Les cultures de LJ positives ont ensuite été analysées avec un dosage rapide de l'antigène de la 
tuberculose (SD-Bioline) afin de différencier le complexe Mycobacterium tuberculosis (MTBC) des mycobactéries non 
tuberculeuses (NTM).                               
Résultats: Sur les 2212 patients suspects de tuberculose, 300 (13,6%) étaient positifs pour AFB par microscopie, la zone 
A (Kaduna North) présentant le plus grand nombre de cas positifs avec 169 (15,2%). Sur les 300 échantillons AFB 
positifs, 272 (91,0%) étaient positifs en culture sur le milieu LJ, 18 (6,0%) étaient négatifs en culture et 10 (3,0%) 
étaient contaminés par la culture. Le résultat de la distribution des mycobactéries parmi les patients infectés dans la zone 
d'étude a révélé que 219 (80,5%) étaient infectés par le MTBC, 42 (15,4%) avec les NTM et 11 (4,0%) avec les deux 
types de MTBC.                              
Conclusion: Un nombre relativement élevé de tuberculose dans la zone d'étude a été causée par les MNT. Il existe un 
besoin d'outils de diagnostic avancés permettant de différencier les souches de MTBC et de MNT parmi les patients 
atteints de tuberculose dans tous les laboratoires de référence pour la tuberculose au Nigeria. 
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Introduction:  
 Mycobacterium tuberculosis also known as 
the tubercle bacilli is a pathogenic bacterium of 
the genus Mycobacterium and the causative agent 
of most cases of tuberculosis (1, 2). First 
discovered in 1882 by Robert Koch, M. 
tuberculosis has an uncommon waxy layer on its 
cell surface (primarily mycolic acid) which makes 
the cell impervious to Gram staining, hence acid-
fast detection techniques are used for its 
identification in the laboratory (3, 4). Mycobact- 
erium tuberculosis is a non-motile and non sporu- 
lating rod. In smears stained with carbol fuschin 
or auramine and examined under the light 
microscope, the tubercle bacilli typically appear as 
straight or slightly curved rods but depending on 
growth conditions and age of the culture, bacilli 
may vary in size and shape from short coccobacilli 
to long rods. The dimensions of the bacilli have 
been reported to be 1-10µm in length (usually 3-
5µm), and 0.2-0.6 µm in width (5, 6). 
 Tuberculosis (TB) has a long history. It 
had existed before the establishment of recorded 
history and has left its mark on human creativity, 
music, art, and literature. It has also influenced 
the advancement of biomedical sciences and 
healthcare and may have killed more persons 
than any other microbial pathogen (7, 8). This 
disease known in the past as the “White Plague” 
is an ancient disease. Recent genetic evidence 
suggests that even our remote hominid ancestors, 
who lived three million years ago, may have 
suffered from TB (6, 9). 
 Mycobacterium tuberculosis forms a 
complex that comprises members implicated in 
human tuberculosis. The complex comprises 
seven members; M. tuberculosis, Mycobacterium 
bovis, Mycobacterium africanum, Mycobacterium 
canettii, Mycobacterium microti, Mycobacterium 
caprae and Mycobacterium pinnipedii. Mycobact- 
erium tuberculosis is the primary causative agent 
of human TB; M. bovis is responsible for bovine 
TB and includes the vaccine strain M. bovis BCG; 
M. africanum is the main causative agent of TB in 
West Africa (10) while M. canetti is a rare MTBC 
strain which produces smooth and glossy 
colonies, with all cases so far isolated from people 
who have been to the horn of Africa (5, 11); M. 
pinnipedii  has been shown to be responsible for 
TB in marine host while M. caprae is responsible 
for TB in goats and M. microti  infects larger 
mammals. Mycobacterium tuberculosis as the 
predominant cause of human TB is the most 
successful of human bacterial pathogens, and is 
sometimes referred to as Koch’s bacillus after the 
discoverer (12). 
 While the disease is preventable and 
curable, TB has remained a significant cause of 
morbidity and mortality in resource limited 
nations (13). Currently it has re-emerged in 
developed nations as well due to its synergy with 
human immunodeficiency virus/acquired immune 
deficiency syndrome, demographic changes and 
human migrations (14, 15). On the basis of 
tuberculin reactivity, one third of the world’s 
population is believed to be infected with latent 
TB. These infected individuals are thus at risk of 
developing TB later in life as their immunity 
wanes from aging or HIV co-infection (2, 16) even 
as TB is a major opportunistic infection in HIV 
infected persons (15, 17). This study was thus 
carried out to characterize mycobacteria among 
presumptive TB patients at the three major TB 
reference hospitals in Kaduna State, Nigeria.   
 




Materials and Methods: 
 
Study area  
 Kaduna State is located in the Northwest 
geo-political zone of Nigeria, lying between 
latitude 6° and 11° North and longitude 7° and 
44° East, and is 608 meters above sea level. The 
study locations were Ahmadu Bello University 
Teaching Hospital Shika, National TB and Leprosy 
Training Centre Zaria and General Hospital 
Kafanchan in Giwa, Zaria and Jama’a Local 
Government Areas respectively (Fig.1).   
 
Study design and population 
 The study is cross sectional, involving TB 
patients attending the Directly Observed 
Treatment Short Course (DOTS) clinics in the 
three senatorial districts of Kaduna State, Nigeria.  
Samples collected were from presumptive TB 
patients attending the DOTS clinics in the selected 
hospitals (Ahmadu Bello University Teaching 
Hospital Shika; National TB Referral Hospital, 
Zaria, and General Hospital, Kafanchan). 
 
Sample size determination 
 Sample size was determined by the 
formula, N=t2pq/d2 (18), where N=minimum 
sample size, t=standard normal distribution at 
95% confidence interval (1.96), d=allowable error 
taken as 0.05, p=known prevalence rate of the 
infection, and q=1-p. The prevalence rate of NTM 
infection (p) used was 15.5% (19), which gives a 
sample size of 201. To adjust for expected losses 
due to contaminated cultures, non-growth and 
other factors, the calculated sample size was 
increased by 20% (20) to 240. However due to 
differences in the study locations, the sample size 
was increased to 300. The proportion to size 
(PPS) sampling as recommended by the World 
Health Organization (21) was used to allocate 
sample size across the three selected hospitals.    
                                                    
 
Fig. 1: Map of Africa, Nigeria and Kaduna State showing the study locations   




Inclusion and exclusion criteria 
 The inclusion criteria for the study are; 
new smear positive TB patients, willingness to 
participate through informed consent, and 
patients aged 15 years and above. Patients who 
were smear negative, those with confirmed drug 
resistant TB, those on re-treatment TB therapy, 
and those who did not give informed consent 
were excluded  
 
Ethical approval    
 Ethical approval for this study was 
obtained from the State Ministry of Health, 
Kaduna State, Nigeria. 
 
Collection of demographic and clinical data 
 A structured questionnaire was used to 
collect demographic characteristics (age, sex, 
ethnicity, education, and marital status), 
health/behavioral factors (HIV, diabetes, smoking, 
alcohol use), environmental exposures (farming, 
animal contact, and dust season) and clinical 
variables (site, smear results) from each subject. 
 
Sputum sample collection 
 One spot sputum sample was collected in 
a labeled standard screw-capped leak-proof 
sputum container with specific clinic identification 
and study numbers according to the National TB 
programme guidelines. 
Sputum transportation 
 Sputum smear microscopy was performed 
at the study sites, and AFB smear positive 
specimens were transported in cold boxes packed 
with ice and thermometer (to monitor 
temperature) within 4 days of collection to the 
National TB Reference Laboratory by a courier 
company. Before transportation, the specimens 
were kept in a refrigerator at 2-8oC.  
Culture of specimens  
 All clinical specimens were processed in a 
Biological Safety Cabinet (BSC) using the NALC-
NaOH method as described by Steingart et al., 
(22). Equal volume (5ml) of NALC-NaOH and 
sputum were mixed. The mixture was vortexed 
and incubated for 15 minutes, and 35 ml 
Phosphate buffer was added to the NALC-NaOH-
sputum mixture and the tubes centrifuged at 4oC 
for 15 minutes at 3000 x g. The supernatant was 
carefully discarded and the sediment was re-
suspended in 2 ml buffer. Exactly 0.1 ml of the 
sediment was inoculated into Lowenstein Jensen’s 
(LJ) slants and incubated in 370C incubator as 
described by Cadmus et al., (23). Smears were 
prepared from the portion of the sediment as 
described by Angra (24). 
 
Sputum microscopy 
 The heat fixed smear was allowed to cool 
and stained with 1% carbol fuschin solution and 
heated from beneath by using spirit lamp until 
steam comes off from the stain. The stain was 
allowed to act on the smear for 10 minutes and 
the procedure was repeated 3 times. The slides 
were tilted to remove excess stain and washed 
gently with running tap water. Decolorization was 
done after rinsing the slides with water and 
flooded with 3% acid alcohol for 2-3 minutes. The 
slides were then rinsed with water and flooded 
with 0.1% methylene blue for 1 minute. The 
slides were rinsed with water and allowed to air 
dry (25). The acid fast bacilli (AFB) load was 
recorded according to the International Union 
against Tuberculosis and Lung Disease (IUATLD) 
standard (26). 
Results:   
Prevalence of mycobacteria by microscopy  
 Of the 2212 patients with suspected TB 
whose sputum were tested from the three 
Senatorial zones, 300 (13.6%) samples were 
positive by AFB microscopy (Fig. 2) 
 
Distribution of mycobacteria by microscopy 
in the study area 
 The result obtained showed that samples 
collected from Zone A (Kaduna North senatorial 
zone) National TB Reference Hospital, Saye-Zaria, 
had the highest number of TB positive cases of 
169 (15.2%) followed by Zone B (Kaduna Central 
Senatorial zone) ABUTH, Shika with 94 (13.4%) 
and Zone C (Kaduna South Senatorial zone) 
General Hospital, Kafanchan with the lowest 37 
(9.3%) (Table 1) 
 
 



















Table 1: Frequency distribution of TB by microscopy in the study area 
Study site Number of samples 
collected 
Number of positive 
samples 
Prevalence (%) 
Zone A (North) 
 
1112 169 15.2 
Zone B (Central) 703 94 13.4 
 
Zone C (South) 397 37 9.3 
 
Total 2212 300 13.6 





Table 2: Distribution of mycobacteria by culture on Lowenstein Jensen medium 
Culture result Number of patient samples  Percentage (%) 
Positive 272 91.0 
Negative 18 6.0 
Contaminants 10 3.0 
Total 300 100 
 
 
Distribution of positive culture samples  
 The percentage distribution of the 300 
AFB positive samples based on culture on 
Lowenstein Jensen’s (L J) medium is shown in 
Table 2, with 272 (91.0%) culture positive, 18 
(6.0%) culture negative and 10 (3.0%) culture 
contaminated. 
 
Distribution of mycobacteria among culture 
positive participants 
 The distribution of mycobacteria among 
the 272 culture positive participants is shown in 
Table 3 which revealed that MTBC were isolated in 
219 (80.5%), NTM in 42 (15.4%) and co-infection 
of MTBC/NTM in 11 (4.0%) participants. 
  





Table 3: Distribution of mycobacteria among the culture positive participants 
Mycobacteria Number positive Percentage (%) 
MTBC 
NTM 







Total 272 100 




 In this study, the overall prevalence of TB 
by AFB microscopy among patients in Kaduna 
State was 13.6%, and 12.3% by culture. The 
13.6% rate is lower than the 18.6% reported by 
Aliyu (25) and 16.7% reported by Mamuda et al., 
(27). This lower prevalence rate may be due to 
the category of studied subjects but may also not 
be unconnected with the synergistic efforts of the 
stakeholders involved in the control of TB in 
Nigeria. The high (91%) culture positive rate in 
AFB smear positive sputum obtained in this study 
may be due to the fact that samples were 
transported in cold chain and processed within the 
acceptable time limit in a high quality laboratory. 
Our culture positive rate is higher than the 85% 
rate reported by Selvakumar et al., (28) in India 
and close to the 100% rate reported by Simeon et 
al., (29).  
 Clinical specimens from non-sterile body 
sites such as sputum for TB culture are usually 
subjected to pre-treatment process involving 
digestion, homogenization, decontamination and 
concentration to eradicate more rapidly growing 
contaminants such as normal flora (other bacteria 
and fungi) without affecting the viability of the 
mycobacterial organisms that grow slowly (30). 
The contamination rate observed in our study was 
3% and this low rate could be attributed to the 
fact that samples were processed and analyzed in 
high quality standard laboratory. This rate is 
within the acceptable range of WHO established 
standard of 3–5% for solid LJ culture method (31) 
and similar to those of Addo et al., (32) who 
reported 4.3% contamination rate. The conta- 
mination rate in our study is lower than Kassidy et 
al., (33) study in Uganda who reported high 
contamination rate of 31% for solid LJ medium, 
which is far above the recommended threshold of 
5% for laboratories that receive freshly produced 
sputum samples. Our rate is also lower than those 
from studies in Nigeria and Zambia where 
reported contamination rates were 14.7% and 
10.8% respectively (19, 34). 
  Smear positive but culture negative TB 
rate obtained from this study was 6%. This could 
be attributed to dead acid fast bacilli or low 
number of viable bacilli undetected by LJ media or 
the killing action of NaOH used for 
decontamination. This rate is lower than that 
obtained by Mamuda et al., (26) in Nigeria with 
8% and Addo et al., (35) in Ghana with 9.8%.  
 The predominance of M. tuberculosis 
strains in our study is in agreement with studies 
from other African countries (36, 37). However, 
studies from other West African countries have 
reported a range of 9% to 28% of MTBC isolates 
to be M. africanum. Studies by Addo et al., (32), 
Niobe-Eyangoh et al., (36), Traore et al., (38) and 
Gomgnimbou et al., (39) have reported low 
prevalence of M. bovis in the African countries of 
Mali (0.8%), Ghana (3%), Burkina Faso (0%) and 
Cameroun (0.2%). Mycobacterium bovis infection 
mostly results from spread of livestock and or 
their products which may be transmitted through 
other routes than the respiratory system.       
 The MTBC prevalence of 80.5% in our 
study is less than 91% reported by Addo et al., 
(32) in Ghana but similar to the study by Aliyu et 
al., (19) with prevalence rate of 85%. The studies 
by Ani et al., (40) and Cadmus et al., (41) in 
Nigeria and USA reported lower rates of 69% and 
48% respectively. The high prevalence of MTBC 
(80.5%) in our study when compared to the 
prevalence of NTM (15.4%) disagrees with the 
study of Muyoyeta et al., (34) who reported that 
in prevalence surveys, where mycobacterial 
speciation has been carried out, NTM may be 
three times more commonly found than MTBC in 
humans. This contradiction may be due to 
differences in environmental factors and control 
policies of animal movements and grazing 
activities in Nigeria.    
 The prevalence of 15.4% for NTM in this 
study is lower than the 39% reported in Ibadan 
by Cadmus et al., (41). The reason for this 
difference could be attributed to the lower sample 
size of only 23 patients used in the Ibadan study 
compared to 300 in the present study. 
Furthermore, our NTM prevalence is lower 
compared to the 23.1-26.6% rate reported in 
Northern Nigeria by Mawak et al., (42) and much 
lower than the prevalence of 56.9% reported in a 
study carried out in Taiwan by Chien et al., (43), 
but our rate is similar and comparable to the 
16.5% recently reported in the south-south region 
of the country by Pokam and Asuquo (44) and 
15% reported in a similar study by Kim et al., 
(45). The NTM prevalence in our study is however 




higher than the 11% previously reported by 
Idigbe et al., (46) in Lagos, a city in South-
western Nigeria, and also higher than 11% 
recently reported by Borroni et al., (47) in 
Burkina Faso (a country in West Africa), Machado 
et al., (48) in Ontario Canada, and 6.4% reported 
by Wang et al., (49) in China, another vastly 
developing country but with an improved health 
care system compared to Nigeria.  
 The relatively high prevalence of NTM in 
our study may also be attributed to the fact that 
the study was conducted during both wet (rainy) 
and dry (harmattan) seasons. Harmattan is a 
West African trade wind that occurs during the 
winter and is characterized by heavy amount of 
dust in the air, low humidity, and reduced 
visibility (50). High risks for environmentally 
acquired pulmonary mycobacterial infections have 
been previously reported for individuals with 
occupational exposures to dust (51, 52, 53). The 
prevalence of MTBC/NTM in this study was 4% 
which is lower than the report of Simeon et al., 
(29) who reported 13% from Ibadan. This might 
be due to the differences in sample size used in 
the studies but could also be due to varied 
sociodemographic and environmental factors. 
Conclusion:  
 Based on the findings of this study, we 
conclude that an overall TB prevalence of 13.6% 
by AFB microscopy was obtained, with the highest 
rate of 15.2% in Zone A (Kaduna South). This 
study also reported a high MTBC prevalence rate 
of 80.5% among patients seeking TB treatment 
but confirmed the occurrence of NTM in 15.3% 
among the TB patients. Even though AFB 
microscopy permits a rapid identification of 
mycobacteria, it is not capable of distinguishing 
MTBC from NTM. This poses a great challenge to 
the TB control programme in Nigeria. Hence, 
inclusion of molecular screening assays that is 
capable of rapid detection of NTM infections in 
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